MHCII restriction demonstrates B cells have very limited capacity to activate tumour-specific CD4+ T cells in vivo
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - December 11, 2023 Category: Cancer & Oncology Authors: Thomas V. GuyAlexandra M. TerryHelen M. McGuireElena ShklovskayaBarbara Fazekas de St Grotha T cell Biology Program, Centenary Institute of Cancer Medicine and Cell Biology, Sydney, NSW, Australiab Pillai Labratory, Ragon Institute of MGH, Harvard and MIT Source Type: research

LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - December 8, 2023 Category: Cancer & Oncology Authors: Morten NielsenTine MonbergVibeke SundvoldBenedetta AlbieriDorrit HovgaardMichael M ørk PetersenAnders Krarup-HansenÖzcan MetKetil CamilioTrevor ClancyRichard StratfordBaldur SveinbjornssonØystein RekdalNiels JunkerInge Marie Svanea National Center for Source Type: research

Cerebrospinal fluid immunological cytokines predict intracranial tumor response to immunotherapy in non-small cell lung cancer patients with brain metastases
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - December 7, 2023 Category: Cancer & Oncology Authors: Meichen LiJing ChenHui YuBaishen ZhangXue HouHonghua JiangDan XieLikun Chena Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Chinab State Key Laboratory of Oncology in South China, Guangzhou, Chinac Guangdong Provincial Cl Source Type: research

PD-L1-expressing natural killer cells predict favorable prognosis and response to PD-1/PD-L1 blockade in neuroblastoma
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - December 1, 2023 Category: Cancer & Oncology Authors: Mengjia SongYue HuangYe HongJuan LiuJia ZhuSuying LuJuan WangFeifei SunJunting HuangJiaqian XuYan TangJian-Chuan XiaYizhuo Zhanga Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Cl Source Type: research

Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - November 30, 2023 Category: Cancer & Oncology Authors: H élène PoinotEloïse DupuychaffrayGrégoire ArnouxMontserrat AlvarezJérémie TachetOunss EzzarJonathan MooreOlivia BejuyEulalia OlestiGioele ViscontiVíctor González-RuizSerge RudazJean-Christophe TilleClarissa D. VoegelPatrycja Nowak-SliwinskaCarole Source Type: research

Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLC
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - November 29, 2023 Category: Cancer & Oncology Authors: Stefan KoeckArno AmannJohan KernMarit ZwierzinaEdith LorenzSieghart SopperHeinz ZwierzinaFinn MildnerMartina SykoraSusanne SprungHubert HacklFlorian AugustinHubert T. MaierAndreas PircherGeorg PallDominik WolfGabriele Gameritha Department of Internal Medi Source Type: research

Trial watch: beta-blockers in cancer therapy
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - November 27, 2023 Category: Cancer & Oncology Authors: Killian Carnet Le ProvostOliver KeppGuido KroemerLucillia Bezua Equipe Labellis ée Par La Ligue Contre Le Cancer, Université de Paris, Sorbonne Université, INSERM UMR1138, Centre de Recherche des Cordeliers, Institut Universitaire de France, Paris, Fra Source Type: research

Identification and characterization of the anti-viral interferon lambda 3 as direct target of the Epstein-Barr virus microRNA-BART7-3p
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - November 27, 2023 Category: Cancer & Oncology Authors: Juliane Bl ümkeMarcus BauerChristoforos VaxevanisAndreas WilferOfer MandelboimClaudia WickenhauserBarbara SeligerSimon Jasinski-Bergnera Institute for Medical Immunology, Martin-Luther-University Halle-Wittenberg, Halle, Germanyb Institute for Pathology, Source Type: research

A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - November 27, 2023 Category: Cancer & Oncology Authors: Huiting WuChang LiuQiang YuanYan QiaoYongwei DingLina DuanWenjing LiMengjia ZhangXuhua ZhangYanan JiangJing LuZiming DongTao WangKangdong LiuJimin Zhaoa Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Chin Source Type: research

g-NK cells from umbilical cord blood are phenotypically and functionally different than g-NK cells from peripheral blood
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - November 22, 2023 Category: Cancer & Oncology Authors: Fei GaoMauricio Campos MoraMichael ConstantinidesLo ïs CoenonCaroline MultrierLoïc VaillantTianxiang ZhangMartin Villalbaa Department of Pathology, School of Basic Medicine, Central South University, Changsha, Chinab IRMB, INSERM, CHRU de Montpellier, U Source Type: research

Piezo1 facilitates optimal T cell activation during tumor challenge
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - November 22, 2023 Category: Cancer & Oncology Authors: muta abiffMohammad AlshebremiMelissa BonnerJay T. MyersByung-Gyu KimSuzanne L. TomchuckAlicia SantinDaniel KingsleySung Hee ChoiAlex Y. Huanga Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, USAb Department of M Source Type: research

The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosis
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - November 21, 2023 Category: Cancer & Oncology Authors: Ángela BellaIgnacio MeleroPedro BerraondoFernando Arandaa Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spainb Navarra Institute for Health Research (IDISNA), Pamplona, Spainc Centro de Investigación Biomédica en Red d Source Type: research

Tumor-intrinsic RGS1 potentiates checkpoint blockade response via ATF3-IFNGR1 axis
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - November 21, 2023 Category: Cancer & Oncology Authors: Baojun WangBo JiangLin DuWenyuan ChenQing ZhangWei ChenMeng DingWenmin CaoJie GaoYongming DengYao FuYan LiYonglong XiaoWenli DiaoHongqian Guoa Department of Urology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, N Source Type: research

Cell type-specific induction of ferroptosis to boost antitumor immunity
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - November 20, 2023 Category: Cancer & Oncology Authors: Jiao LiuJingbo LiRui KangDaolin Tanga DAMP Lab, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, Chinab Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, Chinac Department of Surgery, UT Source Type: research

Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - November 13, 2023 Category: Cancer & Oncology Authors: Maximilian MarholdSimon UdovicaAnna HalsteadMona HirdlerMuna FernerKerstin WimmerZsuzsanna Bago-HorvathRuth ExnerFlorian FitzalKathrin Strasser-WeipplTim RobinsonRupert Bartscha Division of Oncology, Department for Medicine I, Medical University of Vienna Source Type: research